Bristol Myers Squibb Co. has identified proteolysis targeting chimera (PROTAC) compounds comprising a E3 ubiquitin ligase-binding moiety coupled to a proto-oncogene tyrosine-protein kinase receptor ...
The different morphologic subtypes of thyroid cancer correlate with specific genetic lesions (see Table 1). Two PROTEIN KINASES, namely, RET, a transmembrane receptor tyrosine kinase, and BRAF, a ...
Early detection of breast cancer using a unique tumor specific antibody. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback